Roche Holding AG (RHHVF)
OTCMKTS · Delayed Price · Currency is USD
409.00
-0.52 (-0.13%)
At close: May 8, 2026
Roche Holding AG Market Cap
Roche Holding AG has a market cap or net worth of $323.69 billion as of May 8, 2026. Its market cap has increased by 29.46% in one year.
Market Cap
323.69B
Enterprise Value
351.71B
Revenue
79.90B
Ranking
n/a
PE Ratio
19.93
Stock Price
$409.00
Market Cap Chart
Since January 2, 1992, Roche Holding AG's market cap has increased from 8.76B to 323.69B, an increase of 3,595.65%. That is a compound annual growth rate of 11.07%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 8, 2026 | 323.69B | -2.36% |
| Dec 30, 2025 | 331.52B | 46.55% |
| Dec 30, 2024 | 226.23B | -3.34% |
| Dec 29, 2023 | 234.04B | -9.76% |
| Dec 30, 2022 | 259.35B | -22.73% |
| Dec 30, 2021 | 335.62B | 12.23% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 843.28M |
| Glass House Brands | 823.14M |
| Nika Pharmaceuticals | 422.78M |
| CytoDyn | 408.82M |
| Elite Pharmaceuticals | 376.86M |
| Northwest Biotherapeutics | 342.30M |
| Silence Therapeutics | 337.25M |
| American Oncology Network | 303.59M |